H. Houston Merritt

From WikiMD's WELLNESSPEDIA

American neurologist

H. Houston Merritt (1902–1979) was a prominent American neurologist known for his contributions to the field of neurology and his role in the development of anticonvulsant medications. He served as a professor and chair of the Department of Neurology at the Columbia University College of Physicians and Surgeons.

Early Life and Education[edit]

Hiram Houston Merritt Jr. was born on January 12, 1902, in Salisbury, North Carolina. He attended the University of North Carolina at Chapel Hill, where he earned his undergraduate degree. Merritt then pursued his medical degree at the Johns Hopkins School of Medicine, graduating in 1926.

Career[edit]

After completing his medical degree, Merritt trained in neurology under the mentorship of Tracy Putnam at the Boston City Hospital. He later joined the faculty at Harvard Medical School and worked at the Massachusetts General Hospital.

In 1948, Merritt was appointed as the chair of the Department of Neurology at the Columbia University College of Physicians and Surgeons, a position he held until 1967. During his tenure, he significantly advanced the field of neurology through both clinical practice and research.

Contributions to Neurology[edit]

Merritt is best known for his pioneering work in the development of anticonvulsant drugs. Along with Tracy Putnam, he discovered the anticonvulsant properties of phenytoin, which became a widely used treatment for epilepsy. This discovery marked a significant advancement in the management of seizure disorders.

Merritt also contributed to the understanding of various neurological conditions, including multiple sclerosis and migraine. His textbook, Merritt's Neurology, first published in 1955, remains a seminal work in the field and continues to be updated and used by medical professionals worldwide.

Legacy[edit]

H. Houston Merritt's impact on neurology is profound, with his work laying the foundation for modern treatments of neurological disorders. His leadership at Columbia University helped establish the institution as a leading center for neurological research and education.

Related Pages[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.